|
Name |
Xanthoquinodin A1
|
Molecular Formula | C31H24O11 | |
IUPAC Name* |
methyl (1R,7R,8S,17S)-8,13,15,20,22-pentahydroxy-24-methyl-11,18,27-trioxo-6-oxaheptacyclo[15.10.2.01,19.03,16.05,14.07,12.021,26]nonacosa-3,5(14),12,15,19,21(26),22,24,28-nonaene-7-carboxylate
|
|
SMILES |
CC1=CC2=C(C(=C1)O)C(=C3C(=O)[C@H]4C=C[C@]3(C2=O)CC5=CC6=C(C(=C45)O)C(=C7C(=O)CC[C@@H]([C@@]7(O6)C(=O)OC)O)O)O
|
|
InChI |
InChI=1S/C31H24O11/c1-11-7-14-20(16(33)8-11)26(37)23-24(35)13-5-6-30(23,28(14)39)10-12-9-17-21(25(36)19(12)13)27(38)22-15(32)3-4-18(34)31(22,42-17)29(40)41-2/h5-9,13,18,33-34,36-38H,3-4,10H2,1-2H3/t13-,18-,30-,31-/m0/s1
|
|
InChIKey |
XCWGCTNGDUDAMO-SLAVHBLRSA-N
|
|
Synonyms |
Xanthoquinodin A1; 151063-27-3; Methyl (1R,7R,8S,17S)-8,13,15,20,22-pentahydroxy-24-methyl-11,18,27-trioxo-6-oxaheptacyclo[15.10.2.01,19.03,16.05,14.07,12.021,26]nonacosa-3,5(14),12,15,19,21(26),22,24,28-nonaene-7-carboxylate; (4R,4aS,7aS,15R)-rel-2,3,4,7,8,13,15,17-octahydro-1,4,12,14,16-pentahydroxy-10-methyl-8,13,17-trioxo-4aH-7a,15-ethenonaphtho[2',3':4,5]cyclohepta[1,2-b]xanthene-4a-carboxylic acid, methyl ester; Xanthoquinodin A1_130144; CHEMBL2333571; HY-N8252; CS-0141881; 2,3,4,7,8,14,15,17-Octahydro-1,4alpha,12,13,16-pentahydroxy-10-methyl-8,14,17-trioxo-4aH-7abeta,15beta-ethenonaphtho[2',3':4,5]cyclohepta[1,2-b]xanthene-4abeta-carboxylic acid methyl ester
|
|
CAS | NA | |
PubChem CID | 21676964 | |
ChEMBL ID | CHEMBL2333571 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 572.5 | ALogp: | 3.0 |
HBD: | 5 | HBA: | 11 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 188.0 | Aromatic Rings: | 8 |
Heavy Atoms: | 42 | QED Weighted: | 0.249 |
Caco-2 Permeability: | -5.745 | MDCK Permeability: | 0.00001270 |
Pgp-inhibitor: | 0.318 | Pgp-substrate: | 0.946 |
Human Intestinal Absorption (HIA): | 0.794 | 20% Bioavailability (F20%): | 0.982 |
30% Bioavailability (F30%): | 0.964 |
Blood-Brain-Barrier Penetration (BBB): | 0.016 | Plasma Protein Binding (PPB): | 87.15% |
Volume Distribution (VD): | 0.618 | Fu: | 5.15% |
CYP1A2-inhibitor: | 0.115 | CYP1A2-substrate: | 0.873 |
CYP2C19-inhibitor: | 0.029 | CYP2C19-substrate: | 0.065 |
CYP2C9-inhibitor: | 0.188 | CYP2C9-substrate: | 0.132 |
CYP2D6-inhibitor: | 0.136 | CYP2D6-substrate: | 0.151 |
CYP3A4-inhibitor: | 0.756 | CYP3A4-substrate: | 0.216 |
Clearance (CL): | 1.174 | Half-life (T1/2): | 0.019 |
hERG Blockers: | 0.055 | Human Hepatotoxicity (H-HT): | 0.209 |
Drug-inuced Liver Injury (DILI): | 0.872 | AMES Toxicity: | 0.123 |
Rat Oral Acute Toxicity: | 0.909 | Maximum Recommended Daily Dose: | 0.956 |
Skin Sensitization: | 0.205 | Carcinogencity: | 0.141 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.005 |
Respiratory Toxicity: | 0.668 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC006102 | 0.870 | D07VLY | 0.270 | ||||
ENC002945 | 0.711 | D0C9XJ | 0.270 | ||||
ENC002486 | 0.420 | D01XDL | 0.268 | ||||
ENC006116 | 0.411 | D01XWG | 0.267 | ||||
ENC003816 | 0.406 | D0H1AR | 0.259 | ||||
ENC000983 | 0.398 | D0R9WP | 0.252 | ||||
ENC000710 | 0.398 | D07JHH | 0.248 | ||||
ENC000954 | 0.398 | D07MGA | 0.248 | ||||
ENC006117 | 0.381 | D0T5XN | 0.247 | ||||
ENC004265 | 0.380 | D0FX2Q | 0.246 |